Sun Pharma
Search results
Jun 12, 2024 · Glenmark is a leading, research–based global pharmaceutical company. KNOW MORE. Glenmark Pharma is discovering advance therapies for a new world. We are creating centers of excellence in dermatology, oncology and...
Glenmark Pharmaceuticals Limited is a research‐led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus in the therapy areas of Respiratory, Dermatology and Oncology.
16 hours ago · Glenmark Pharmaceuticals announced today that its board of directors approved the sale of a 7.84 per cent stake in its subsidiary, Glenmark Life Sciences Limited (GLS). The sale will involve up to 96,09,571 equity shares and will be conducted through an offer for sale (OFS) on the stock exchange. The specific price and date of the offer for sale will likely be announced in the future.
17 hours ago · Glenmark Pharmaceuticals ' board of directors approved the sale of a 7.84% stake or 96,09,571 equity shares, in Glenmark Life Sciences Limited, as stated in its filing to the exchanges on Wednesday. The stake sale will be done through the stock exchanges via an offer for sale (OFS).
The company focused on new drugs [9] and biosimilars in the fields of cancer, dermatology and respiratory diseases, which it sought to monetize by partnering with major pharmaceutical companies. [8] [10] In 2016 it had four such drugs in clinical trials. [11]
Our branded formulations business in India focuses on high growth and large therapy categories such as dermatology, respiratory, cardiovascular, anti-diabetic and oncology. Globally we are also present in therapy categories of gynecology, anti-infective and gastroenterology.
Jul 4, 2024 · Glenmark Pharmaceuticals Limited Stock Price Today, Live NSE Share Price: Get the latest Glenmark Pharmaceuticals Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Get the latest Glenmark Pharmaceuticals Ltd (GLENMARK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
15 hours ago · Glenmark Pharma To Divest 7.84% Stake In Glenmark Life Sciences Through Offer For Sale As per the regulatory filing, the company added that the board approved the sale of up to 96.09 lakh shares ...
16 hours ago · Glenmark Pharma board has approved the sale of a 7.84 per cent stake, which is equivalent to 96,09,571 equity shares, in Glenmark Life Sciences, the company said in an exchange filing on June 10.
